← Back to all trials
Completed
NCT04056260
ICG-NIR Guided Lymph Node Dissection in Gastric Cancer
Conditions: Stomach Neoplasm
Sex: All
Ages: 20 Years – 80 Years
Healthy volunteers: No
Phase: NA
Enrollment: 219
Sponsor: Ho Seok Seo
Location: Seoul St. Mary's Hospital, The Catholic University of Korea Seoul
Summary
As the survival rate of patients with gastric cancer has increased, there has been a growing interest in interventions that improve postoperative quality of life. Therefore minimally invasive surgery or endoscopic resection has been performed much more frequently. However, adequate lymph node dissection is important as well. The aim of the study is to identify the feasibility of indocyanine green - near infra-red (ICG-NIR) guided sentinel lymph node dissection for the treatment of gastric cancer.
Eligibility Criteria
Inclusion Criteria:
* dignosed gastric adenocarcinoma
* tumor: size 4cm or smaller
* depth of invasion: mucosa, submucosa, proper muscle
* candidates of laparoscopic radical gastrectomy
* informed consent
Exclusion Criteria:
* metachronous malignancy
* number of tumors: 2 or more
* remnant gastric cancer
* indication for endoscopic resection
* history of chemotherapy or radiation therapy
* pregnancy
* allergy to ICG
* metastatic gastric cancer
Source: ClinicalTrials.gov (NCT04056260). StuddyBuddy aggregates publicly available trial information.